001     276102
005     20250314091251.0
024 7 _ |a 10.5772/intechopen.1003993
|2 doi
037 _ _ |a DZNE-2025-00183
041 _ _ |a English
100 1 _ |a Adelaja Osibote, Otolorin
|b 0
|e Editor
245 _ _ |a Recent Advances of Copper-64 Based Radiopharmaceuticals in Nuclear Medicine
260 _ _ |c 2024
|b IntechOpen
295 1 0 |a Advances in Dosimetry and New Trends in Radiopharmaceuticals / Adelaja Osibote, Otolorin (Editor) ; : IntechOpen, , Chapter 5 ; ISBN: 978-0-85466-008-7 ; doi:10.5772/intechopen.110965
300 _ _ |a 1 - 24
336 7 _ |a BOOK_CHAPTER
|2 ORCID
336 7 _ |a Book Section
|0 7
|2 EndNote
336 7 _ |a bookPart
|2 DRIVER
336 7 _ |a INBOOK
|2 BibTeX
336 7 _ |a Output Types/Book chapter
|2 DataCite
336 7 _ |a Contribution to a book
|b contb
|m contb
|0 PUB:(DE-HGF)7
|s 1738662662_26729
|2 PUB:(DE-HGF)
520 _ _ |a Copper radioisotopes including copper-60/61/62, and -64 exhibit a wide range of decay characteristics, making them appropriate choices for diagnostic/therapeutic (theranostic) applications in nuclear medicine. One notable feature of copper is the feasible coordination chemistry, which makes radiolabeling of a wide range of chemical structures including antibodies, proteins, peptides, and other biologically relevant small molecules possible. This chapter will summarize common radiopharmaceuticals of copper-64 and their radiation dosimetry in order to highlight recent improvements of positron emission tomography diagnostics.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef Book
700 1 _ |a Eppard, Elisabeth
|b 1
|e Editor
700 1 _ |a Vahidfar, Nasim
|b 2
700 1 _ |a Bakhshi Kashi, Mohsen
|b 3
700 1 _ |a Afshar, Saeed
|b 4
700 1 _ |a Sheikhzadeh, Peyman
|b 5
700 1 _ |a Farzanefar, Saeed
|b 6
700 1 _ |a Salehi, Yalda
|b 7
700 1 _ |a Delpasand, Ebrahim
|b 8
700 1 _ |a Molloy, Eóin N.
|0 P:(DE-2719)9002180
|b 9
700 1 _ |a Mirzaei, Siroos
|b 10
700 1 _ |a Ahmadzadehfar, Hojjat
|b 11
700 1 _ |a Eppard, Elisabeth
|b 12
773 _ _ |a 10.5772/intechopen.1003993
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/276102/files/DZNE-2025-00183.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/276102/files/DZNE-2025-00183.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:276102
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)9002180
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
915 _ _ |a Creative Commons Attribution CC BY 3.0
|0 LIC:(DE-HGF)CCBY3
|2 HGFVOC
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
920 1 _ |0 I:(DE-2719)1311001
|k AG Maaß
|l Multimodal Neuroimaging
|x 0
980 _ _ |a contb
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1311001
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21